About: covid:PMC7159478

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7159478 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Demoly, P. Custovic, A. Mäkelä, M. Johnston, S. Papadopoulos, N. Le Souëf, P. Ryan, D. Akdis, C. Bel, E. Del Giacco, S. Fabbri, L. Gaga, M. Hamelmann, E. Holloway, J. Kalayci, O. Lötvall, J. Magnan, A. Martinez, F. O'Byrne, P. Papi, A. Pavord, I. Saglani, S. Sergejeva, S.
is schema:about of	named entity 'asthma exacerbations' named entity 'asthma' named entity 'eosinophil' named entity 'ppb' named entity 'virus infection' named entity 'confounding factor' named entity 'symptom' named entity 'risk factors' named entity 'asthma' named entity 'treatment-resistant' named entity 'clinical practice' named entity 'Novartis' named entity 'GlaxoSmithKline' named entity 'COPD' named entity 'symptom' named entity 'allergen' named entity 'longitudinal studies' named entity 'atopy' named entity 'asthma' named entity 'Asthma' named entity 'eosinophil' named entity 'Chiesi' named entity 'MedImmune' named entity 'phenotype' named entity 'short-acting' named entity 'Asthma exacerbation' named entity 'obstructive sleep apnoea' named entity 'FEV1' named entity 'FEV1' named entity 'biomarkers' named entity 'Chiesi' named entity 'asthma' named entity 'asthma exacerbations' named entity 'Orion Pharma' named entity 'Astra Zeneca' named entity 'clinical symptoms' named entity 'wheezing' named entity 'asthma' named entity 'Chiesi' named entity 'asthma' named entity 'asthma exacerbation' named entity 'asthma exacerbations' named entity 'vitamin' named entity 'asthma' named entity 'birth cohort' named entity 'D. Ryan' named entity 'inhaled steroid' named entity 'phenotypic' named entity 'Glaxo Smith Kline' named entity 'particulate matter' named entity 'obesity' named entity 'antiviral' named entity 'Novartis' named entity 'asthmatic' named entity 'MedImmune' named entity 'phenotype' named entity 'eosinophil' named entity 'inflammation' named entity '85%' named entity 'Case-control studies' named entity 'asthma exacerbation' named entity 'asthma' named entity 'asthma' named entity 'sputum' named entity 'asthma' named entity 'LABAs' named entity 'asthmatic' named entity 'Australian Research Council' named entity 'standard treatment' named entity 'LABA' named entity 'asthma' named entity 'longitudinal study' named entity 'clinical symptoms' named entity 'Rhinovirus' named entity 'asthma' named entity 'Novartis' named entity 'ALK'

Attributes

Values

Creator

Demoly, P.
Custovic, A.
Mäkelä, M.
Johnston, S.
Papadopoulos, N.
Le Souëf, P.
Ryan, D.
Akdis, C.
Bel, E.
Del Giacco, S.
Fabbri, L.
Gaga, M.
Hamelmann, E.
Holloway, J.
Kalayci, O.
Lötvall, J.
Magnan, A.
Martinez, F.
O'Byrne, P.
Papi, A.
Pavord, I.
Saglani, S.
Sergejeva, S.

is schema:about of

named entity 'asthma exacerbations'
named entity 'asthma'
named entity 'eosinophil'
named entity 'ppb'
named entity 'virus infection'
named entity 'confounding factor'
named entity 'symptom'
named entity 'risk factors'
named entity 'asthma'
named entity 'treatment-resistant'
named entity 'clinical practice'
named entity 'Novartis'
named entity 'GlaxoSmithKline'
named entity 'COPD'
named entity 'symptom'
named entity 'allergen'
named entity 'longitudinal studies'
named entity 'atopy'
named entity 'asthma'
named entity 'Asthma'
named entity 'eosinophil'
named entity 'Chiesi'
named entity 'MedImmune'
named entity 'phenotype'
named entity 'short-acting'
named entity 'Asthma exacerbation'
named entity 'obstructive sleep apnoea'
named entity 'FEV1'
named entity 'FEV1'
named entity 'biomarkers'
named entity 'Chiesi'
named entity 'asthma'
named entity 'asthma exacerbations'
named entity 'Orion Pharma'
named entity 'Astra Zeneca'
named entity 'clinical symptoms'
named entity 'wheezing'
named entity 'asthma'
named entity 'Chiesi'
named entity 'asthma'
named entity 'asthma exacerbation'
named entity 'asthma exacerbations'
named entity 'vitamin'
named entity 'asthma'
named entity 'birth cohort'
named entity 'D. Ryan'
named entity 'inhaled steroid'
named entity 'phenotypic'
named entity 'Glaxo Smith Kline'
named entity 'particulate matter'
named entity 'obesity'
named entity 'antiviral'
named entity 'Novartis'
named entity 'asthmatic'
named entity 'MedImmune'
named entity 'phenotype'
named entity 'eosinophil'
named entity 'inflammation'
named entity '85%'
named entity 'Case-control studies'
named entity 'asthma exacerbation'
named entity 'asthma'
named entity 'asthma'
named entity 'sputum'
named entity 'asthma'
named entity 'LABAs'
named entity 'asthmatic'
named entity 'Australian Research Council'
named entity 'standard treatment'
named entity 'LABA'
named entity 'asthma'
named entity 'longitudinal study'
named entity 'clinical symptoms'
named entity 'Rhinovirus'
named entity 'asthma'
named entity 'Novartis'
named entity 'ALK'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software